<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04979104</url>
  </required_header>
  <id_info>
    <org_study_id>H-36</org_study_id>
    <nct_id>NCT04979104</nct_id>
  </id_info>
  <brief_title>Hip Arthroplasty With SL Cementless</brief_title>
  <official_title>A Post-market Study Evaluating Clinical and Radiographic Early Outcomes pf Hip Arthroplasty With SL Cementless Stem.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Limacorporate S.p.a</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Limacorporate S.p.a</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to evaluate the clinical, radiographical and patient-reported outcomes&#xD;
      measurements up 3 years FU and to assess the survivorship of SL Cementless Stem after partial&#xD;
      or total hip arthroplasty.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 8, 2021</start_date>
  <completion_date type="Anticipated">June 8, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 8, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The trial is open-label, not randomized, retrospective and longitudinal cohort clinical study. The follow up outcomes of each patient are compared with the baseline measurements of the same subject (preoperative assessment for clinician-based evaluations and patient-reported outcomes; immediate postoperative assessment for the radiographical evaluation)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implant radiographic stability</measure>
    <time_frame>3 years FU</time_frame>
    <description>Radiographic implant evaluation and stability assessment of the SL Cementless Stem on collected radiographs as per clinical practice during hospitalization and routine visits.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical outcomes</measure>
    <time_frame>6 weeks, 3 months, 1 year, 3 years after surgery</time_frame>
    <description>Assessment of the clinical evaluation of the SL Cemetless Stem used in real life settings over a period of 3 years through PROMs if available and medical evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant safety profile</measure>
    <time_frame>6 weeks, 3 months, 1 year, 3 years after surgery</time_frame>
    <description>Incidence, type and severity of all Adverse Events (AEs), Serious Adverse Events (SAEs), Adverse Device Effect (ADEs), Serious Adverse Device Effects (SADEs) at intraoperatively/discharge, 6 weeks, 3 months, 1 year, 3 years after the implant;</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Hip Replacement</condition>
  <arm_group>
    <arm_group_label>SL Cementless</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Since the trial is not comparative, the only arm implies the use of the investigational device (SL cementless femoral stem)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hip arthroplasty with SL Cementless</intervention_name>
    <description>Total or partial hip arthroplasty with implant of SL cementless femoral stem.</description>
    <arm_group_label>SL Cementless</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients that underwent to partial or total hip arthroplasty and implanted with SL&#xD;
             cementless stem between Jan 2012 and Jan 2020 at Nemocnice Kyjov Hospital (CZ) in&#xD;
             accordance with the indication for use of the product and site standard of practice.&#xD;
&#xD;
          -  Patients' radiographs availability of at least 4 of the 6 visits (mandatory baseline&#xD;
             radiographs).&#xD;
&#xD;
          -  Patient is willing and able to complete additional follow-up evaluations if needed&#xD;
             after signing ICF;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years;&#xD;
&#xD;
          -  Female patients who are pregnant, nursing, or planning a pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Federica Azzimonti</last_name>
    <phone>+39 377 5450940</phone>
    <email>federica.azzimonti@limacorporate.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gaia Pacassoni</last_name>
    <phone>+39 366 6248631</phone>
    <email>gaia.pacassoni@limacorporate.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nemocnice Kyjov Hospital</name>
      <address>
        <city>Kyjov</city>
        <state>CZ Republic</state>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin BÃ¬la</last_name>
    </contact>
    <investigator>
      <last_name>Martin Bila</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 16, 2021</study_first_submitted>
  <study_first_submitted_qc>July 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2021</study_first_posted>
  <last_update_submitted>July 16, 2021</last_update_submitted>
  <last_update_submitted_qc>July 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cementless femoral stem</keyword>
  <keyword>Hip arthroplasty</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

